Rapidly Advancing a Pipeline of Precision Medicines for the Brain
Our drugs target core brain processes, with the goal of improving these functions along with improving symptoms.
Cognition
Cognition
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
![](https://cdn.prod.website-files.com/613fc091ade68f6a117755a3/62855fd90da0da2956e909dd_Frame%2022442-1.svg)
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
Emotion and its Regulation
Emotion and its Regulation
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
![](https://cdn.prod.website-files.com/613fc091ade68f6a117755a3/62856047fb506d0ade58c862_Frame%2022537.svg)
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
Sleep and Activity
Rarely directly assessed or quantified, includes alterations in either sleep or circadian rhythms.
Sleep and Activity
![](https://cdn.prod.website-files.com/613fc091ade68f6a117755a3/62855fd9ec4fb94d88bb1ba2_Frame%2022442.svg)
Rarely directly assessed or quantified, includes alterations in either sleep or circadian rhythms.
Rarely directly assessed or quantified, includes alterations in either sleep or circadian rhythms.
Cognition
Cognition
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
![](https://cdn.prod.website-files.com/613fc091ade68f6a117755a3/62855fd90da0da2956e909dd_Frame%2022442-1.svg)
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
A major driver of disability and poor outcome, includes attention, decision-making, learning memory, and neuroplasticity.
Emotion and its Regulation
Emotion and its Regulation
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
![](https://cdn.prod.website-files.com/613fc091ade68f6a117755a3/62856047fb506d0ade58c862_Frame%2022537.svg)
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia)
Sleep and Activity
Often a difficult-to-treat feature, includes excessive negative (anxiety) or diminished positive emotion (anhedonia).
Sleep and Activity
![](https://cdn.prod.website-files.com/613fc091ade68f6a117755a3/62855fd9ec4fb94d88bb1ba2_Frame%2022442.svg)
Rarely directly assessed or quantified, includes alterations in either sleep or circadian rhythms.
Rarely directly assessed or quantified, includes alterations in either sleep or circadian rhythms
PRODUCT CANDIDATE
(TARGET)
ALTO-100
(BDNF)
MDD, PTSD, Bipolar Depression
100'S SERIES NOVEL COMBINATIONS
100 SERIES
(C-AMP PATHWAY)
100 SERIES - 3 NOVEL COMBINATIONS
100 SERIES
(C-AMP PATHWAY)
200'S SERIES NOVEL COMBINATIONS
200 SERIES
(DOPAMINE PATHWAY)
Neuropsychiatric, Neurodegenerative
200 SERIES - 3 NOVEL COMBINATIONS
200 SERIES
(DOPAMINE PATHWAY)
Neuropsychiatric, Neurodegenerative
Cognition Pathway Targeting
Emotion Pathway Targeting
Receive updates from Alto
© Alto Neuroscience 2024